Mr. Mirsaidi brings both practical and strategic senior management experience for young start-ups to Fortune 100 companies, with a proven track record in the industry. He held several senior level management positions in his ten-year career at Nichols Institute Diagnostics (a division of Quest Diagnostics). As general manager and executive director at Ontogen, a small molecule discovery company, he managed operations of a subsidiary focused on high-throughput synthesis and purification of novel chemical compounds. Mr. Mirsaidi served as Vice President at AltheaDx, a spinout from Althea Technologies, a San Diego biologics GMP manufacturing company, and most recently served as CEO and founder of Molecular Response, LLC, a CRO focused on translational oncology.